Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on the Pharmacokinetics of HRS-4642 in Healthy Participants
NCT07894679Phase 1Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Oct 2026
- Primary completion
- Nov 2026
01
Overview
Phase 1, open-label, single-arm trial of HRS-4642 in cancer, sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Maximum Observed Plasma Concentration. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
HRS-4642
03
Conditions
cancer
Beyond the preview
Go deeper on NCT07894679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07894679.